EGFR and breast cancer: Interestingly, GEPs induced by different concentrations of ORes were significantly enriched in the PI3K-AKT signalling pathway downstream of EGFR, and activation of the EGFR/PI3K/AKT/GPX4 axis was associated with poor prognosis in breast cancer patients.